Form PRE 14C - Other preliminary information statements:
SEC Accession No. 0001641172-25-010024
Filing Date
2025-05-13
Accepted
2025-05-14 08:50:08
Documents
2
Period of Report
2025-05-13

Document Format Files

Seq Description Document Type Size
1 PRE 14C formpre14c.htm PRE 14C 170842
2 GRAPHIC formpre14c_001.jpg GRAPHIC 14327
  Complete submission text file 0001641172-25-010024.txt   191907
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14C | Act: 34 | File No.: 000-50626 | Film No.: 25942936
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)